Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Ruby Gadelrab, Jorge Velarde

Premium

Ruby Gadelrab has been named vice president of commercial marketing for 23andMe. Gadelrab most recently served as head of marketing and commercial development at Invitae, and prior to that had worked at Affymetrix, where she most recently served as head of international marketing and clinical development. She also has worked at Life Technologies, Dharmacon, and AbGene.


BaseHealth has tapped Jorge Velarde to serve as its CEO and president. He is taking over from Hossein Fakhrai-Rad, current chairman of the board, who is now transitioning into a new role as the company's chief scientific officer.

Before taking on the role of CEO, Velarde was the interim CEO and senior vice president of business development and marketing at BaseHealth. Before he joined the company, Velarde was vice president of business development at Illumina. He also worked in business development at Gen-Probe, which was acquired by Hologic in 2012.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.